Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients
- PMID: 27744039
- DOI: 10.1016/j.jcin.2016.07.021
Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients
Abstract
Objectives: The aim of this study was to evaluate the clinical usefulness of intravascular ultrasound (IVUS)-guided new-generation drug-eluting stent (DES) implantation using a meta-analysis of individual patient-level data from randomized trials.
Background: Published randomized trials that compare IVUS-guided versus angiography-guided new-generation DES implantation are scarce.
Methods: Searches of the MEDLINE, Embase, and Cochrane databases were performed to find randomized trials that compared IVUS-guided versus angiography-guided new-generation DES implantation. A total of 2,345 patients from 3 randomized trials were identified, and all patients were treated for long lesions or chronic total occlusions. Individual patient-level data were obtained. The primary endpoint was a major adverse cardiac event, a composite of cardiac death, myocardial infarction, or stent thrombosis. An intention-to-treat analysis and per protocol analysis were performed.
Results: By 1 year post-procedure, major adverse cardiac events had occurred in 0.4% of the patients who underwent IVUS-guided DES implantation versus 1.2% of those who underwent angiography-guided DES implantation (hazard ratio [HR]: 0.36; 95% confidence interval [CI]: 0.13 to 0.99; p = 0.040). For the IVUS-guided group, favorable clinical outcomes were observed for myocardial infarction (0% vs. 0.4%; HR: 0.09; p = 0.026). In addition, the clinical benefit of IVUS guidance was stronger in the per protocol analysis (HR: 0.32; 95% CI: 0.12 to 0.89; p = 0.021).
Conclusions: Compared with angiographic guidance, IVUS-guided new-generation DES implantation was associated with favorable outcomes in terms of major adverse cardiac events, the composite of cardiac death, myocardial infarction, or stent thrombosis. These findings must be interpreted only for complex lesions, because all identified patients had long lesions or chronic total occlusions.
Keywords: coronary artery disease; drug-eluting stent(s); intravascular ultrasound.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Comment in
-
Long Lesions, Hard Endpoints, and Intravascular Ultrasound.JACC Cardiovasc Interv. 2016 Nov 14;9(21):2240-2242. doi: 10.1016/j.jcin.2016.07.041. Epub 2016 Oct 12. JACC Cardiovasc Interv. 2016. PMID: 27744038 No abstract available.
-
Intravascular Ultrasound-Guided PCI: Undervalued Since its Inception.JACC Cardiovasc Interv. 2017 Feb 27;10(4):417. doi: 10.1016/j.jcin.2016.12.006. JACC Cardiovasc Interv. 2017. PMID: 28231911 No abstract available.
-
Reply: Intravascular Ultrasound-Guided PCI: Undervalued Since its Inception.JACC Cardiovasc Interv. 2017 Feb 27;10(4):418. doi: 10.1016/j.jcin.2016.12.267. JACC Cardiovasc Interv. 2017. PMID: 28231912 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
